Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Differences in Body Composition Across Levels of Disability Among Ambulatory Patients Living With Multiple Sclerosis: 2569 Board #92 June 3, 9: 30 AM - 11: 00 AM.
The Wnt Effector Transcription Factor 7-Like 2 Positively Regulates Oligodendrocyte Differentiation in a Manner Independent of Wnt/β-Catenin Signaling.
'The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level - YES'.
HLA associations in South Asian multiple sclerosis.
Emotional dysfunctions in neurodegenerative diseases.
Effects of Intermittent Versus Continuous Walking on Distance Walked and Fatigue in Persons With Multiple Sclerosis: A Randomized Crossover Trial.
Do not judge a cell by its cover-diversity of CNS resident, adjoining and infiltrating myeloid cells in inflammation.
Myeloradicular Form of Neuroschistosomiasis in a Six-Year-Old Boy Infected With Schistosoma mansoni.
Altered Oligodendrocyte Maturation and Myelin Maintenance: The Role of Antiretrovirals in HIV-Associated Neurocognitive Disorders.
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.
Long live the axon. Parallels between ageing and pathology from a presynaptic point of view.
Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis.
P2X Receptors as Drug Targets.
Betulinic acid regulates generation of neuroinflammatory mediators responsible for tissue destruction in multiple sclerosis in vitro.
Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
[Neuroimmunology: theoretical and clinical aspects].
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
Vitamin D and the central nervous system.
Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis.
Smoking and risk of treatment-induced neutralizing antibodies to interferon β-1a.
Screening for inhibitors of microglia to reduce neuroinflammation.
Direct-to-consumer genomic testing offers little clinical utility but appears to cause minimal harm.
A Review of the Psychometric Properties of Generic Utility Measures in Multiple Sclerosis.
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps.
A unified cell biological perspective on axon-myelin injury.
Pages
« first
‹ previous
…
486
487
488
489
490
491
492
493
494
…
next ›
last »